We hypothesize that amyloid B-protein (ABeta) assembly into oligomers and polymers is a seminal neuropathogenetic process in Alzheimer's disease (AD) and in cerebral amyloid angiopathy (CAA). Inhibiting formation of, or disrupting, ABeta assemblies thus could be of benefit in the treatment of these disorders. To test this hypothesis, detailed knowledge of the folding and assembly of ABeta is necessary. In this proposal, we seek to understand the structural and kinetic features of ABeta fibrillogenesis in order to facilitate later rational design and testing of therapeutic agents. Our prior work in this area has contributed to the discovery and characterization of heretofore-unrecognized conformational and structural intermediates in the assembly process, e.g., protofibrils. In fact, protofibrils have been found to be toxic to cultured neurons and new studies suggest that protofibrils may be key pathogenetic effectors of the Arctic form of familial Alzheimer's disease. Here, we have proposed an ambitious plan that seeks to eventually provide a rigorous structural and thermodynamic elucidation of the entire pathway through which nascent ABeta folds and assembles. Key areas of focus are the early oligomerization of ABeta monomer, the formation of an a-helix-containing conformational intermediate, protofibril assembly, assembly-dependent changes in the topology of amino acids in ABeta, and how the biophysical effects of AD- and CAA-linked amino acid substitutions correlate with the disease phenotype. These studies will contribute to our understanding of AD and CAA. In addition, because amyloid assemblies from most, if not all, of the -20 different kinds of amyloidoses share certain common structural features, the data generated here also should be relevant to these other disorders.
Three Specific Aims are proposed:
Aim 1. To characterize the conformational, morphologic, and assembly dynamics associated with key intermediates in fibril formation.
Aim 2. To determine the topological organization of amino acids during ABeta folding and assembly.
Aim 3. To determine the effects of novel AD- and CAA-associated amino acid substitutions on ABeta folding and assembly.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
7R01NS038328-07
Application #
7024732
Study Section
Special Emphasis Panel (ZRG1-BDCN-3 (01))
Program Officer
Oliver, Eugene J
Project Start
1998-12-10
Project End
2006-05-31
Budget Start
2004-09-02
Budget End
2005-05-31
Support Year
7
Fiscal Year
2004
Total Cost
$522,796
Indirect Cost
Name
University of California Los Angeles
Department
Neurology
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Yu, Xinke; Hayden, Eric Y; Xia, Ming et al. (2018) Surface enhanced Raman spectroscopy distinguishes amyloid ?-protein isoforms and conformational states. Protein Sci 27:1427-1438
Hayden, Eric Y; Conovaloff, Joseph L; Mason, Ashley et al. (2017) Preparation of pure populations of covalently stabilized amyloid ?-protein oligomers of specific sizes. Anal Biochem 518:78-85
Yamin, Ghiam; Teplow, David B (2017) Pittsburgh Compound-B (PiB) binds amyloid ?-protein protofibrils. J Neurochem 140:210-215
Do, Thanh D; LaPointe, Nichole E; Nelson, Rebecca et al. (2016) Amyloid ?-Protein C-Terminal Fragments: Formation of Cylindrins and ?-Barrels. J Am Chem Soc 138:549-57
Yamin, Ghiam; Coppola, Giovanni; Teplow, David B (2016) Design, Characterization, and Use of a Novel Amyloid ?-Protein Control for Assembly, Neurotoxicity, and Gene Expression Studies. Biochemistry 55:5049-60
Kim, Bongkeun; Do, Thanh D; Hayden, Eric Y et al. (2016) Aggregation of Chameleon Peptides: Implications of ?-Helicity in Fibril Formation. J Phys Chem B 120:5874-83
Bilousova, Tina; Miller, Carol A; Poon, Wayne W et al. (2016) Synaptic Amyloid-? Oligomers Precede p-Tau and Differentiate High Pathology Control Cases. Am J Pathol 186:185-98
Hayden, Eric Y; Yamin, Ghiam; Beroukhim, Shiela et al. (2015) Inhibiting amyloid ?-protein assembly: Size-activity relationships among grape seed-derived polyphenols. J Neurochem 135:416-30
Yamin, Ghiam; Huynh, Tien-Phat Vuong; Teplow, David B (2015) Design and Characterization of Chemically Stabilized A?42 Oligomers. Biochemistry 54:5315-21
Roychaudhuri, Robin; Zheng, Xueyun; Lomakin, Aleksey et al. (2015) Role of Species-Specific Primary Structure Differences in A?42 Assembly and Neurotoxicity. ACS Chem Neurosci 6:1941-55

Showing the most recent 10 out of 62 publications